GS
Goldman Sachs Alternatives
Goldman Sachs Alternatives is a Series A to growth stage investment firm. It has made 36 investments. Deal activity decreased year-over-year (5 deals in the last 12 months vs 11 prior). Average disclosed round size is $328.6M (across 38 rounds with reported amounts).
Portfolio
36
Fund Size
—
Top Stage
Series B
Last 12 Mo
5
Team
EC
Elliot Chovev
Managing Director
TM
Teresa Mattamouros
Managing Director
DA
Darius Adamczyk
Partner
BT
Brian Thompson
Associate
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
44 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Owner | Growth | $240M | Aug 2026 |
| SSage | Series C | $65M | Mar 2026 |
 Third Arc Bio | Series A | $52M | Feb 2026 |
 Redwood Materials | Series E | — | Jan 2026 |
 osapiens | Series C | $100M | Jan 2026 |
 Owner.com | Growth | $240M | Jan 2026 |
 AlphaSense | Series C | $350M | Jan 2026 |
 AlphaSense | Growth | $100M | Jan 2026 |
 Sidewinder | Series B | $137M | Jan 2026 |
 Float | Series C | — | Jan 2026 |
 LegalOn Technologies | Series E | $50M | Jul 2025 |
| LLegalOn Technologies, Inc. | Series E | $50M | Jul 2025 |
 Aidoc | Series E | $150M | Jul 2025 |
 Rippling | Series G | $450M | May 2025 |
 Attovia Therapeutics | Series C | $90M | Apr 2025 |
 Navina | Series C | $55M | Mar 2025 |
 Newleos | Series A | $93.5M | Feb 2025 |
| NNewleos Therapeutics | Series A | $93.5M | Feb 2025 |
| Newleos | Series A | $93M | Jan 2025 |
| NNewleos Therapeutics | Series A | $93.5M | Jan 2025 |
 EvolvedMD | Series B | $34M | Jan 2025 |
 Seaport Therapeutics | Series B | $225M | Oct 2024 |
| TTriveni | Series B | $115M | Oct 2024 |
 Vicebio | Series B | $100M | Sep 2024 |
| osapiens | Series B | — | Jul 2024 |
Page 1 of 2
Top Co-Investors
The Goldman Sachs Group, Inc.8 shared
Longwood Fund5 shared
Boxer Capital5 shared
OrbiMed5 shared
The Invus Group, LLC5 shared
Arkin Bio Ventures4 shared
Novo Holdings A/S4 shared
Blue Owl Capital3 shared
Colt Ventures3 shared
Canaan Partners3 shared
Nextech Invest Ltd.3 shared
Digitalis Ventures3 shared
Y Combinator3 shared
Sands Capital3 shared
Cormorant Asset Management3 shared
Viking Global Investors3 shared
D. E. Shaw Ventures3 shared
Realty Corporation3 shared
Last updated: 7 October 2026